infantile spasm, psychomotor retardation, and hypsarrhythmia on electroencephalography (EEG). It primarily develops between the ages of 3 months and 1 year, with an average incidence of 0.31 per 1000 live births and a male/female ratio of 1.12-1.42. 1 The prognosis is grave with a mortality rate of 12%, and fewer than 16% of survivors attain normal mental development. 1 Most patients are left with marked mental deficiency and intractable seizures, often in the form of Lennox-Gastaut syndrome (LGS) 2, 3 ; these children account for roughly 15-25% of cases of LGS. 4 The prognosis for LGS is somewhat better than that of WS: the mortality rate is 5%, 5 and mental retardation, often associated with autism, is present in 90% of cases. 6 Roughly 80% of affected children experience intractable seizures of multiple types. 7 Frequent epileptic falls (due mainly to atonic, massive myoclonic, and generalized tonic-clonic seizures) with resultant injuries are a major problem in daily care of these patients. Only a very small proportion of cases (approximately 10%), mostly cryptogenic, experience full remission of their seizures, but many of these patients will still continue to have subnormal mental development. 8 Corpus callosotomy has been reported to be effective in some patients with LGS. 7 The symptomatic type of LGS has a poor prognosis, particularly if it is preceded by WS. 9 Pinard et al. reported that anterior callosotomy was most useful against the cryptogenic form of LGS and was not effective in patients with preceding WS. 10 Thus, we are interested in the effect of callosotomy for our patients with LGS evolving from WS and those whose LGS was not preceded by WS. Therefore, we retrospectively compared post-callosotomy seizure outcomes for both types of children and analyzed differences in major features of the two groups.
Methods
We retrospectively analyzed the records of patients with LGS who received corpus callosotomy from September 1989 to May 1999 at our hospital. All patients were followed for more than 4 years. All patients fulfilled the triad of diagnostic criteria for LGS (e.g., mental retardation, multiple seizure types, and generalized slow spike-and-wave complexes on interictal EEGs) and had medically intractable seizures. Medical intractability was defined as the presence of the following: (1) seizures refractory to most currently available anticonvulsants and occurring despite the presence of anticonvulsants within documented therapeutic serum levels; (2) seizure frequency of more than two episodes per month without two weeks free of seizures; (3) close supervision for at least 1 year by qualified epileptologists. The infantile spasms were diagnosed by qualified pediatric epileptologists.
All patients had been admitted to the Pediatric Epilepsy Monitoring Unit of Taipei Veterans General Hospital and received 24-h digital 16-channel-telemetric Video/EEG monitoring by either the Telefactor or Cadwell Spectrum 32 system. Each patient was required to have at least three maximally disabling habitual seizures recorded during the monitoring period. Each Video/EEG was reviewed by a qualified pediatric epileptologist and an electroencephalographer. Magnetic resonance imaging (MRI) was performed for all patients with T1 weighted, T2 weighted, and occasional proton density or gadolinium-enhanced images. Positron emission tomography (PET) scans were done using 18-FDG (18-fluorodeoxyglucose) as the tracer to measure cerebral glucose metabolism was also performed for all patients. Other presurgical evaluations that were routinely performed included neuropsychological assessment and determination of current serum antiepileptic drug levels. The callosotomy was performed under direct visualization via operative microscope and was divided from the genu backward to the tip of the hippocampal commissure for a length of about 4-7 cm (2/3 to 5/6 of corpus callosum, varied due to different degrees of difficulty in surgical approach).
Postoperative seizure outcome was classified into seven grades: Grade 1, seizure free without anticonvulsant therapy; Grade 2, seizure free with anticonvulsant therapy; Grade 3, seizure reduction of more than 50%; Grade 4, seizure reduction of less than 50%; Grade 5, no change in either frequency or severity of seizures before and after surgery; Grade 6, worsening of seizures postoperatively; Grade 7, death of patient. Significant improvement was defined as outcome Grade 1, 2, or 3.
A x 2 -test was used where appropriate for comparison of the localization of epileptiform discharges and postoperative seizure outcome between groups. A p-value of <0.05 was considered to be statistically significant.
Results
From September 1989 to May 1999, 74 consecutive eligible patients entered the study. There were 53 (71.6%) male and 21 (28.4%) female patients. Ages ranged from 1 to 30 years (mean age, 9.1 years), and seizure onset ranged from age 0 to 13 years (mean, 2.6 years). Age at time of surgery ranged from 1 to 30 years (mean, 9.1 years). (Table 2) .
Regarding all seizure types as a whole, the analysis of overall postoperative seizure outcome in all 74 patients revealed that 14 patients (18.9%) were Grade 2, 31 patients (41.9%) were Grade 3, 13 patients (17.6%) were Grade 4, 13 patients (17.6%) were Grade 5, 2 patients (2.7%) were Grade 6, and 1 patient (1.3%) was Grade 7; thus, 45 of 74 patients (60.8%) achieved significant improvements after callosotomy. In the 21 Group A (positive WS) patients, five patients (23.8%)
554
S.-Y. Kwan et al. Table 3 ). The average outcome was slightly higher, at Grade 3.58. Thus, 29 of 53 patients (54.7%) achieved significant improvement after callosotomy (Table 4) . There is no significant statistical difference in postoperative seizure outcome between Group A and Group B (average Grade 3.19 versus 3.58, p = 0.0880). In the subset of patients with cryptogenic disease, four patients (80%) in Group A had significant improvement, whereas 13 patients (76.5%) in Group B had significant improvement.
When postoperative seizure outcome for Groups A and B was analyzed by seizure type, there was again no statistical significance in the difference between groups (Table 5 ).
Discussion
In our 74 patients with LGS, 21 patients (28.4%) had a history of WS, whereas 53 patients (71.6%) did not have a history of WS, with average age of seizure onset at 2.6 years. These data are close to figures cited in previous reports (15-25% with WS, 3-5 years at seizure onset, 60% without history of WS). 11 The onset of the WS in our series was 0.88 years (10 months), which is mildly later than previous report (peak at 6 months).
1 One of our patients had relatively late onset at the age of 13 years, however, similar finings were reported by Callosotomy in LGS with and without WS 555 Group A: positive history for West syndrome; Group B: negative history for West syndrome; G1: Grade 1, seizure free without anticonvulsant therapy; G2: Grade 2, seizure free with anticonvulsant therapy; G3: Grade 3, seizure reduction of more than 50%; G4: Grade 4, seizure reduction of less than 50%; G5: Grade 5, no change in either frequency or severity of seizures before and after surgery; G6: Grade 6, worsening of seizures postoperatively; G7: Grade 7, death of patient. Roger et al. 12 The overall ratio of patients who achieved significant improvement after callosotomy was 60.8% (45 of 74 patients), which is also concordant with findings from previous reports with LGS (range of 50-77%). 13 In one series, anterior callosotomy was most useful against the cryptogenic form of LGS and was not effective in patients with preceding WS. 10 However, in another report, callosotomy enhanced seizure control in two thirds of patients with a history of WS.
14 In our patient series, there was a total of 24 patients who had cryptogenic etiology, and 17 (70.8%) of them had significant improvement after surgery. In Group A (positive WS), 16 patients (76.2%) had significant improvement. Our result is compatible with the report that suggested callosotomy was most useful for patients with the cryptogenic form of LGS, but our results also suggest that callosotomy is effective in patients whose LGS evolved from WS.
We hypothesized that Group A would have poorer postoperative outcomes than Group B, but our results did not support it. Possible explanations include the following: (1) younger ages at time of surgery and (2) shorter duration between seizure onset and callosotomy in Group A (positive WS) than in Group B. In any case, our findings suggest that the presence of a history of WS in LGS does not necessarily indicate a poor outcome after callosotomy.
There has been considerable debate about the proper classification of infantile spasms and tonic seizures. The classic spasm begins with a rapid, often jerk like, tonic contraction of trunk and limb musculature, which gradually relaxes over 0.5-2.0 s. Fusco and Vigevano argued that infantile spasms should not be considered simply as brief tonic seizures because of the age-specific occurrence, uniformly brief, spasm-like muscle involvement, and the characteristic interictal and ictal EEG. 15 Egli et al. and Ikeno et al. highlight the overlap between the infantile spasm and brief tonic seizures in older children and adults. 16, 17 Egli et al. suggested that very brief tonic seizures in older children be termed axial spasms. 16 Ikeno et al. suggested that axial spasms in older children and adults are the same as infantile spasms seen in WS. 17 Donat and Wright reported that the infantile spasm is very similar to the brief tonic seizures if clustered in series in older children or adults in ictal posture and EEG. 18 Therefore, the tonic seizures in infants have also been referred to as infantile spasms. These might explain the higher percentage of generalized tonic seizures in Group A than Group B in our series (52.4% versus 30.2%), which suggests that most infantile spasm persist into late childhood and have a close link with the generalized tonic seizures seen in LGS.
In conclusion, our study data suggest that there is no difference in post-callosotomy outcome between LGS patients with and without a history of WS.
